- Home
- ULH vs AUTL Comparison
ULH vs AUTL Comparison
Compare ULH & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- AUTL
- Stock Information
- Founded
- ULH 1932
- AUTL 2014
- Country
- ULH United States
- AUTL United Kingdom
- Employees
- ULH N/A
- AUTL N/A
- Industry
- ULH Trucking Freight/Courier Services
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ULH Industrials
- AUTL Health Care
- Exchange
- ULH Nasdaq
- AUTL Nasdaq
- Market Cap
- ULH 635.2M
- AUTL 625.4M
- IPO Year
- ULH 2005
- AUTL 2018
- Fundamental
- Price
- ULH $23.34
- AUTL $2.38
- Analyst Decision
- ULH Hold
- AUTL Strong Buy
- Analyst Count
- ULH 1
- AUTL 5
- Target Price
- ULH $29.00
- AUTL $9.32
- AVG Volume (30 Days)
- ULH 57.6K
- AUTL 1.5M
- Earning Date
- ULH 07-24-2025
- AUTL 08-12-2025
- Dividend Yield
- ULH 1.85%
- AUTL N/A
- EPS Growth
- ULH N/A
- AUTL N/A
- EPS
- ULH 2.31
- AUTL N/A
- Revenue
- ULH $1,668,148,000.00
- AUTL $9,011,000.00
- Revenue This Year
- ULH N/A
- AUTL $472.28
- Revenue Next Year
- ULH $7.88
- AUTL $114.92
- P/E Ratio
- ULH $10.02
- AUTL N/A
- Revenue Growth
- ULH N/A
- AUTL N/A
- 52 Week Low
- ULH $20.60
- AUTL $1.11
- 52 Week High
- ULH $53.29
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- ULH 38.21
- AUTL 49.35
- Support Level
- ULH $24.92
- AUTL $2.23
- Resistance Level
- ULH $30.76
- AUTL $2.60
- Average True Range (ATR)
- ULH 1.67
- AUTL 0.14
- MACD
- ULH -0.53
- AUTL -0.04
- Stochastic Oscillator
- ULH 0.00
- AUTL 31.91
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.